With no exemptions for medical devices from Trump’s double-digit tariffs, pacemakers, insulin pumps and hearing aids could all cost more.| Forbes
Kailera jumped the weight loss miracle-drug line by licensing four clinical-stage obesity therapies from China, which is quickly emerging as a powerhouse pharmaceutical R&D center.| Forbes
Big Pharma and biotech startups alike are counting on AI to speed the process of drug discovery and make their operations more efficient. But most of the best data scientists aren’t working in healthcare—at least not yet.| Forbes
In this week’s edition of InnovationRx, we look at the impact of tariffs on healthcare costs, pioneers of treating MS, AI for clinical decision-making, and more.| Forbes